↓ Skip to main content

Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
16 tweeters
f1000
1 research highlight platform

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
266 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd003794.pub4
Pubmed ID
Authors

Luis Javier Nannini, Phillippa Poole, Stephen J Milan, Rebecca Holmes, Rebecca Normansell

Abstract

Both long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS) have been recommended in guidelines for the treatment of chronic obstructive pulmonary disease (COPD). Their coadministration in a combination inhaler may facilitate adherence to medication regimens and improve efficacy.

Twitter Demographics

The data shown below were collected from the profiles of 16 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 266 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 1%
Brazil 2 <1%
South Africa 1 <1%
Indonesia 1 <1%
Chile 1 <1%
Netherlands 1 <1%
Tunisia 1 <1%
Spain 1 <1%
United States 1 <1%
Other 0 0%
Unknown 254 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 48 18%
Researcher 40 15%
Student > Ph. D. Student 29 11%
Student > Bachelor 25 9%
Student > Postgraduate 21 8%
Other 62 23%
Unknown 41 15%
Readers by discipline Count As %
Medicine and Dentistry 133 50%
Nursing and Health Professions 19 7%
Social Sciences 13 5%
Agricultural and Biological Sciences 11 4%
Pharmacology, Toxicology and Pharmaceutical Science 11 4%
Other 30 11%
Unknown 49 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2017.
All research outputs
#1,309,538
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#3,607
of 8,923 outputs
Outputs of similar age
#21,160
of 177,640 outputs
Outputs of similar age from Cochrane database of systematic reviews
#48
of 110 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,640 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.